Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-23-015782
Filing Date
2023-05-08
Accepted
2023-05-08 16:05:19
Documents
1
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 ownership.html 5  
1 ownership.xml 5 3554
  Complete submission text file 0001493152-23-015782.txt   5034
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Issuer) CIK: 0001618835 (see all company filings)

EIN.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EVOFEM BIOSCIENCES, INC. 12400 HIGH BLUFF DRIVE, SUITE 600 SAN DIEGO CA 92130
Business Address
File Justin J. (Reporting) CIK: 0001726277 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-36754 | Film No.: 23897694